Taysha Gene Therapies, Inc. ( TSHA) - Key Metrics
TSHA Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.02 | -$0.09 | -$0.08 | -$0.08 |
| 2025Q3 | ? | -$0.09 | -$0.07 | -$0.07 |
| 2025Q2 | $0.01 | -$0.09 | -$0.07 | -$0.07 |
| 2025Q1 | $0.01 | -$0.08 | -$0.08 | -$0.08 |
TSHA Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -15.78 |
| 2025Q3 | ? | -8.82 |
| 2025Q2 | ? | -6.40 |
| 2025Q1 | ? | -4.35 |
TSHA
Price: $5.50
52 week price:
Earnings Per Share: -0.38 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1.1 million
Market Capitalization: 1.7 billion